Nuclear Stocks To Watch Today - November 2nd

Key Points

• Seven stocks are highlighted as nuclear-related names to watch: Oklo (OKLO), NuScale Power (SMR), BWX Technologies (BWXT), Centrus Energy (LEU), X-Energy (XE), Nano Nuclear Energy (NNE), and Karyopharm Therapeutics (KPTI), selected for their recent trading volume.
• The group spans the nuclear-energy supply chain, including advanced and modular reactor developers, nuclear-component manufacturers, uranium and fuel suppliers, and nuclear-fuel recycling services.
• Investors seeking nuclear exposure should consider risks including regulation, safety concerns, project costs, uranium prices, and shifts in public policy; the sector is also benefiting from rising electricity demand tied to AI and data centers.

Oklo, NuScale Power, BWX Technologies, Centrus Energy, X-Energy, Nano Nuclear Energy, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat's stock screener tool. “Nuclear stocks” are shares of companies involved in the nuclear-energy industry, such as uranium miners, reactor manufacturers, nuclear plant operators, and related engineering or fuel suppliers. Investors often view them as a way to gain exposure to growing electricity demand and low-carbon energy, but they can be affected by regulation, safety concerns, project costs, uranium prices, and public policy. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.

Oklo (OKLO)

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.

Read Our Latest Research Report on OKLO

NuScale Power (SMR)

NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.

Read Our Latest Research Report on SMR

BWX Technologies (BWXT)

BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.

Read Our Latest Research Report on BWXT

Centrus Energy (LEU)

Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.

Read Our Latest Research Report on LEU

X-Energy (XE)

X-energy is a leading designer of advanced nuclear reactor technology (commonly referred to as small modular reactors, “SMRs”) and manufacturer of advanced nuclear fuels. We believe these scalable, power generation technologies help satisfy historically unprecedented electricity demand growth, driven by the development of AI and associated data center infrastructure.

Read Our Latest Research Report on XE

Nano Nuclear Energy (NNE)

Read Our Latest Research Report on NNE

Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).

Read Our Latest Research Report on KPTI

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.